-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Janssen invites you to learn about a treatment for adult patients with RRMM who have received at least four prior lines of therapy, including a PI, IMiD, and anti-CD38 monoclonal antibody

Sponsor: Johnson & Johnson
Program: Product Theaters
Sunday, December 10, 2023: 11:30 AM-12:30 PM
Room 1B (San Diego Convention Center)
Agne Paner-Straseviciute, MD, Johnson & Johnson
No relevant conflicts of interest to declare.
For In-Person Participants Only
See more of: Product Theaters